...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >ASTRAGALOSIDE IV ATTENUATES HYPOXIA-INDUCEDCARDIOMYOCYTE DAMAGE IN RATS BY UPREGULATINGSUPEROXIDE DISMUTASE-1 LEVELS
【24h】

ASTRAGALOSIDE IV ATTENUATES HYPOXIA-INDUCEDCARDIOMYOCYTE DAMAGE IN RATS BY UPREGULATINGSUPEROXIDE DISMUTASE-1 LEVELS

机译:黄芪总苷IV通过上调超氧化物歧化酶-1水平减轻大鼠低氧诱导的心肌细胞损伤

获取原文
获取原文并翻译 | 示例
           

摘要

1. Astragaloside IV (AST-IV) is purified from a natural plant product. Previous studies have shown that AST-IV has antioxidant activity. In the present study, we investigated the effect and mechanism of action AST-IV on rat cardiomyocytes subjected to hypoxic conditions (up to 12 h).2. Cardiomyocytes were prepared from neonatal rats and cultured under normoxic or hypoxic conditions in the absence or presence of AST-IV (12.5, 25 or 50 (mu)g/mL,). Cell viability, malondialdehyde (MDA) levels, activity and expression of superoxide dismutase (SOD)-l (mRNA and protein levels determined by reverse transcription-polymerase chain reaction and western blotting, respectively) and reactive oxygen species (ROS; determined by 2',7'-dichlorodihydrofluorescein diacetate) were investigated under these culture conditions. Intracellular localization of AST-IV was tested using fluorescein isothiocyanate-labelled AST-IV.3. Hypoxic culture reduced the viability of cardiomyocytes, which was improved following treatment with 25 or 50 (mu)g/mL AST-IV. Under hypoxic conditions, MDA levels were double those under control conditions. Astragaloside IV (25 and 50 (mu)G/mL) dose-dependently reduced the increase in MDA seen in hypoxic cardiomyocytes.4. Fluorescein isothiocyanate-labelled AST-IV entered cardiomyocytes and was localized mainly within the cytoplasm.5. Under hypoxic conditions, SOD-1 activity was decreased, but mRNA and protein expression increased, compared with normoxia. Following treatment with 25 (mu)g/mL AST-IV, SOD-1 activity and expression were increased under both normoxic and hypoxic conditions. The ROS scavenging effect of AST-IV was abolished in the presence of the SOD inhibitor sodium diethyl dithiocarbamate (25 (mu)mol/L).6. These in vitro results show that AST-IV protects cardiomyocytes from oxidative stress-mediated injury under hypoxicconditions. A major part of this action is achieved by upregulation of SOD-1 content and activity within the cell cytoplasm.
机译:1.黄芪甲苷IV(AST-IV)是从天然植物产品中纯化得到的。先前的研究表明AST-IV具有抗氧化活性。在本研究中,我们研究了AST-IV对缺氧条件下(长达12小时)大鼠心肌细胞的作用及其机制。2。从新生大鼠制备心肌细胞,并在缺氧或缺氧条件下,在无或有AST-IV(12.5、25或50μg/ mL)的条件下培养心肌细胞。细胞活力,丙二醛(MDA)水平,超氧化物歧化酶(SOD)-1的活性和表达(mRNA和蛋白质水平分别通过逆转录聚合酶链反应和Western印迹确定)和活性氧(ROS;通过2'确定)在这些培养条件下研究了7,-二氯二氢荧光素二乙酸酯。使用荧光素异硫氰酸酯标记的AST-IV测试AST-IV的细胞内定位。低氧培养降低了心肌细胞的活力,用25或50μg/ mL AST-IV处理后,心肌细胞的活力得到改善。在低氧条件下,MDA水平是对照条件下的两倍。黄芪甲苷IV(25和50μG/ mL)剂量依赖性地降低了低氧心肌细胞中MDA的增加4。异硫氰酸荧光素标记的AST-IV进入心肌细胞,主要定位在细胞质内。5。在缺氧条件下,与正常氧相比,SOD-1活性降低,但mRNA和蛋白质表达增加。用25μg/ mL AST-IV处理后,在常氧和低氧条件下,SOD-1活性和表达均增加。在SOD抑制剂二乙基二硫代氨基甲酸钠(25μmol/ L)的存在下,AST-IV的ROS清除作用消失了。6。这些体外结果表明,AST-IV在缺氧条件下保护心肌细胞免受氧化应激介导的损伤。该作用的主要部分是通过上调细胞质中SOD-1的含量和活性来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号